2025-03-012026-02-282026-02-28false11820425MOSS PHARMA SOLUTIONS LIMITED2026-07-0970229falseiso4217:GBPxbrli:pure118204252025-02-28118204252026-02-28118204252025-03-012026-02-28118204252024-02-29118204252025-02-28118204252024-03-012025-02-2811820425bus:Micro-entities2025-03-012026-02-2811820425bus:AuditExempt-NoAccountantsReport2025-03-012026-02-2811820425bus:FullAccounts2025-03-012026-02-2811820425bus:PrivateLimitedCompanyLtd2025-03-012026-02-2811820425core:WithinOneYear2026-02-2811820425core:AfterOneYear2026-02-2811820425core:WithinOneYear2025-02-2811820425core:AfterOneYear2025-02-2811820425dpl:CostSales2025-03-012026-02-2811820425dpl:AdministrativeExpenses2025-03-012026-02-2811820425dpl:DistributionCosts2025-03-012026-02-2811820425dpl:CostSales2024-03-012025-02-2811820425dpl:AdministrativeExpenses2024-03-012025-02-2811820425dpl:DistributionCosts2024-03-012025-02-2811820425core:WithinOneYear2026-02-2811820425core:AfterOneYear2026-02-2811820425core:WithinOneYear2025-02-2811820425core:AfterOneYear2025-02-2811820425core:WithinOneYear2025-03-012026-02-2811820425core:AfterOneYear2025-03-012026-02-2811820425bus:Director12025-03-012026-02-28

MOSS PHARMA SOLUTIONS LIMITED

Registered Number
11820425
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2026

MOSS PHARMA SOLUTIONS LIMITED
Company Information
for the year from 1 March 2025 to 28 February 2026

Director

MOSS, Michael John

Registered Address

Wey Court West
Union Road
Farnham
GU9 7PT

Registered Number

11820425 (England and Wales)
MOSS PHARMA SOLUTIONS LIMITED
Statement of Financial Position
28 February 2026

2026
£

2025
£

Fixed Assets3,5463,895
Current Assets10,175526
Prepayments and accrued income-72
Creditors amounts falling due within one year(17,608)(4,408)
Net current assets (liabilities)(7,433)(3,810)
Total assets less current liabilities(3,887)85
Creditors amounts falling due after one year-(590)
Accruals and deferred income(10,565)-
Net assets (liabilities)(14,452)(505)
Capital and reserves(14,452)(505)
The financial statements were approved and authorised for issue by the Director on 9 July 2026, and are signed on its behalf by:
MOSS, Michael John
Director
Registered Company No. 11820425